Wang AY - Search Results

1

Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.

Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Matsushita K, et al. Among authors: wang ay. Nat Rev Nephrol. 2022 Nov;18(11):696-707. doi: 10.1038/s41581-022-00616-6. Epub 2022 Sep 14. Nat Rev Nephrol. 2022. PMID: 36104509 Review.

2

Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.

Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, Sanderson JE. Wang AY, et al. Among authors: wang m. J Am Soc Nephrol. 2004 Aug;15(8):2186-94. doi: 10.1097/01.ASN.0000135053.98172.D6. J Am Soc Nephrol. 2004. PMID: 15284304

3

Cardiovascular risk factors in peritoneal dialysis patients revisited.

Wang AY. Wang AY. Perit Dial Int. 2007 Jun;27 Suppl 2:S223-7. Perit Dial Int. 2007. PMID: 17556309 Review.

4

Use of cardiac biomarkers in end-stage renal disease.

Wang AY, Lai KN. Wang AY, et al. J Am Soc Nephrol. 2008 Sep;19(9):1643-52. doi: 10.1681/ASN.2008010012. Epub 2008 Mar 5. J Am Soc Nephrol. 2008. PMID: 18322158 Review.

5

Consequences of chronic inflammation in peritoneal dialysis.

Wang AY. Wang AY. Semin Nephrol. 2011 Mar;31(2):159-71. doi: 10.1016/j.semnephrol.2011.01.005. Semin Nephrol. 2011. PMID: 21439430 Review.

6

Cardiovascular risk in diabetic end-stage renal disease patients.

Wang AY. Wang AY. J Diabetes. 2011 Jun;3(2):119-31. doi: 10.1111/j.1753-0407.2011.00113.x. J Diabetes. 2011. PMID: 21599866 Review.

7

Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.

Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH, Lo G, Lai KN, Lo WK, Lam CW, Yu CM. Wang AY, et al. J Am Soc Nephrol. 2014 Jan;25(1):175-86. doi: 10.1681/ASN.2013010103. Epub 2013 Sep 19. J Am Soc Nephrol. 2014. PMID: 24052631 Free PMC article. Clinical Trial.

8

Skin autofluorescence associates with vascular calcification in chronic kidney disease.

Wang AY, Wong CK, Yau YY, Wong S, Chan IH, Lam CW. Wang AY, et al. Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1784-90. doi: 10.1161/ATVBAHA.114.303378. Epub 2014 May 29. Arterioscler Thromb Vasc Biol. 2014. PMID: 24876353

9

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J. Grams ME, et al. Among authors: wang ay. Kidney Int. 2018 Jun;93(6):1442-1451. doi: 10.1016/j.kint.2018.01.009. Epub 2018 Mar 29. Kidney Int. 2018. PMID: 29605094 Free PMC article.

10

Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625-637.

Chronic Kidney Disease Prognosis Consortium. Chronic Kidney Disease Prognosis Consortium. Kidney Int Rep. 2018 Aug 30;3(6):1506. doi: 10.1016/j.ekir.2018.08.009. eCollection 2018 Nov. Kidney Int Rep. 2018. PMID: 30450480 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

870 results

Search Page